Evidence map›Paper›PMID 19571879›Full record

ArticleNature2009

Telomerase modulates Wnt signalling by association with target gene chromatin.

Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji and 5 more

Abstract read
In one paragraph

Article in Nature, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 387 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
387citing papers in PubMed, 3 pooled it
21.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

387 citing papers in PubMed, 3 syntheses or guidelines pooled it, 689 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Telomerase-Associated Genes as Prognostic Markers in High-Grade Serous Ovarian Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Telomerase mRNA therapy protects human skin against radiation-induced DNA damage.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  19. Article
  20. Review

327 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Jae-Il ParkDepartment of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Andrew S Venteicher
Ji Yeon Hong
Jinkuk Choi
Sohee Jun
Marina Shkreli
Woody Chang
Zhaojing Meng
Peggie Cheung
Hong Ji
Margaret McLaughlin
Timothy D Veenstra
Roel Nusse
Pierre D McCrea
Steven E Artandi
Stanford University · USThe University of Texas MD Anderson Cancer Center · USScience Applications International Corporation (United States) · USApplied BioPhysics (United States) · USMassachusetts Institute of Technology · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
p120-catenin sub-family functionsR01GM052112 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MCCREA, PIERRE D · 1995 to 2010
$3.5M
Telomeres, Telomerase and Tumor ProgressionR01CA111691 · NCI · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2005 to 2015
$2.8M
Regulation of the Telomerase Protein Component In CancerR01CA125453 · NCI · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2006 to 2015
$2.2M
NCI NIH HHS CA111691NCI NIH HHS CA125453NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA111691NCI NIH HHS R01 CA125453NIGMS NIH HHS R01 GM052112
6 · The paper itself

Abstract

Stem cells are controlled, in part, by genetic pathways frequently dysregulated during human tumorigenesis. Either stimulation of Wnt/beta-catenin signalling or overexpression of telomerase is sufficient to activate quiescent epidermal stem cells in vivo, although the mechanisms by which telomerase exerts these effects are not understood. Here we show that telomerase directly modulates Wnt/beta-catenin signalling by serving as a cofactor in a beta-catenin transcriptional complex. The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (also called SMARCA4), a SWI/SNF-related chromatin remodelling protein, and activates Wnt-dependent reporters in cultured cells and in vivo. TERT serves an essential role in formation of the anterior-posterior axis in Xenopus laevis embryos, and this defect in Wnt signalling manifests as homeotic transformations in the vertebrae of Tert(-/-) mice. Chromatin immunoprecipitation of the endogenous TERT protein from mouse gastrointestinal tract shows that TERT physically occupies gene promoters of Wnt-dependent genes. These data reveal an unanticipated role for telomerase as a transcriptional modulator of the Wnt/beta-catenin signalling pathway.

Indexed as

Signal TransductionAnimalsbeta CateninCell LineChoristomaChromatinDNA HelicasesGenes, ReporterHeLa CellsHumansIntestine, SmallMiceNuclear ProteinsOocytesPlasmidsPromoter Regions, Geneticbeta CateninChromatinDNA HelicasesNuclear ProteinsSmarca4 protein, mouseTelomeraseTert protein, mouseTranscription FactorsWnt3 ProteinWnt Proteins

Identifiers

PMID19571879
PMCPMC4349391
OpenAlexW2086316954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.